Cell-based and selected cell-free therapies for myocardial infarction: how do they compare to the current treatment options?

HIGHLIGHTS

• who: Mu00e1ria Csu00f6bu00f6nyeiovu00e1 et al. from the National Institute of Rheumatic Diseases, Nu00e1breu017eie IKrasku, , Pieu0161t`any, Institute of Histology and Embryology, Faculty of Medicine, Comenius University, have published the research work: Cell-Based and Selected Cell-Free Therapies for Myocardial Infarction: How Do They Compare to the Current Treatment Options?, in the Journal: (JOURNAL)
• what: The main focus is on the expeditious opening of the affected vessel within the treatment algorithm of AMI .
• how: This drug algorithm is used to prevent left ventricle remodeling and to avoid the progression of the atherosclerotic process . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.